| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3877136 | The Journal of Urology | 2006 | 4 Pages |
Abstract
The UroVysion⢠fluorescence in situ hybridization assay is significantly more sensitive than voided cytology for detecting bladder cancer in patients evaluated for gross or microscopic hematuria for all grades and stages. Based on these data UroVysion⢠was approved by the Food and Drug Administration for use in patients with hematuria.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Michael F. Sarosdy, Paul R. Kahn, Mark D. Ziffer, William R. Love, Jack Barkin, Emmanuel O. Abara, Ken Jansz, Julia A. Bridge, Sonny L. Johansson, Diane L. Persons, Jane S. Gibson,